Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 2014
  • 2015
  • 2016
  • …
  • ›
  • »

2026-04-22

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

2026-04-22

EQT Chief Sees AI Rout as Opportunity for Fresh Tech Bets

2026-04-22

Best Buy taps insider Bonfig to succeed veteran Barry as CEO

2026-04-22

Masco Corp. Reveals Advance In Q1 Income

2026-04-22

CME Group, Inc. Q1 Income Climbs

2026-04-22

Windfall Geotek Deploys AI-Powered Targeting Gold, Silver & Copper on Hi-View Resources Toodoggone Project, British Columbia

2026-04-22

Element 29 Resources Inc.: Element 29 Closes $35.4 M Private Placement with 9.9% Interest Acquired by Strategic Investor

2026-04-22

Travel giant Tui takes £35m hit from Middle East war and slashes profit forecasts

2026-04-22

UN Warns Of Major Food Crisis As Fertilizer Shipments Held At Hormuz

2026-04-22

Banyan Group Releases 2025 Sustainability Report, Marking 20 Years of Reporting and 100-Property Milestone

2026-04-22

Tractor Supply is the most oversold consumer discretionary stock as Q1 earnings roll on

2026-04-22

Alterity Therapeutics Presents New Analysis of ATH434 Phase 2 Trial Data in Late Breaking Science Session of the American Academy of Neurology

  • «
  • ‹
  • …
  • 2014
  • 2015
  • 2016
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies